Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 784.818 million compared to CNY 448.598 million a year ago. Operating income was CNY 44.221 million compared to operating loss of CNY 73.688 million a year ago. Net income was CNY 22.958 million compared to net loss of CNY 73.443 million a year ago. Basic earnings per share from continuing operations was CNY 0.0238 compared to basic loss per share from continuing operations of CNY 0.076 a year ago.